"How is your company at the "investor dance"? In this session, a diverse panel of investor relations and money management professionals will share their perspectives on shareholder company compatibility and shareholder targeting, as well as best practices for developing and sustaining relationships with institutional investors. In addition, the panel will discuss the evolving and varied role hedge funds are playing in driving stock liquidity and valuation and how biotech companies can most
effectively interact with these firms."

Objective1:Demonstrate approaches to investor targeting that increase access to potential investors while supporting management's goal of optimizing the company shareholder mix.

Objective2:Educate executives on the goals of hedge funds, the implications of their explosive growth in recent years and the opportunities and risks they present.

Objective3:Identify practices that help sustain relationships and credibility with core investors.